Literature DB >> 3347042

Estrogen and antiestrogen interaction with estrogen receptor of MCF-7 cells--relationship between processing and estrogenicity.

M Gyling1, G Leclercq.   

Abstract

Overnight preincubation of MCF-7 cells with 2 x 10(-10) M estradiol (E2) produces a dramatic reduction of their specific [3H]E2 binding capacity. Scatchard plot analysis revealed that this loss of estrogen receptor (ER) concentration, usually termed "processing", occurs without any significant modification of binding properties of the unprocessed receptors. Direct measurement of ER (ER-EIA from Abbott) gave residual receptor concentrations close to those established by binding assay indicating that processing involves the loss of at least one epitope other than the steroid binding site. Incubation with increasing amounts of E2 (0.1 to 5 x 10(-10) M) resulted in an increasing reduction of binding capacity indicating that the extent of processing is associated with the hormone concentration. Steroidal estrogens other than E2 as well as antiestrogens of the triphenylethylene category behaved similarly in this regard although the latter compounds usually acted only when at higher concentrations. The processing capacity of a large series of ligands was compared with the corresponding binding affinity for ER as assessed by classical competitive inhibition of [3H]E2 binding in both cytosol and whole cells. For steroidal estrogens, a large spectrum of concordant values was found which correlated with the known uterotrophic activity of the compounds. On the contrary, weak estrogen and antiestrogens of the triphenylethylene category displayed low processing capacities which were in the order of magnitude of the binding affinities established in whole cells; these values were considerably lower than the corresponding values measured in the cytosol. These observations are consistent with the concept that the capacity of a ligand to process ER is related to its agonistic activity. They also support our hypothesis (J. steroid Biochem. 25 (1986) 677-682) that assessment of the ability of a ligand to inhibit the binding of [3H]E2 in whole cells provides an estimate of its agonistic activity, an estimate which can not be established in the corresponding cytosol assay.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3347042     DOI: 10.1016/0022-4731(88)90368-8

Source DB:  PubMed          Journal:  J Steroid Biochem        ISSN: 0022-4731            Impact factor:   4.292


  7 in total

1.  Use of alpha-, beta-Estrogen Receptor as a "new tool" for detection of specific small molecule activity.

Authors:  Samir Kumar Gunjan; Dennis Trent Rogers; Jingxian Zhang; Kil-Young Yun; Deane L Falcone; John Littleton
Journal:  Plant Mol Biol Report       Date:  2015-03-26       Impact factor: 1.595

2.  Antiestrogenic properties of keoxifene, trans-4-hydroxytamoxifen, and ICI 164384, a new steroidal antiestrogen, in ZR-75-1 human breast cancer cells.

Authors:  R Poulin; Y Merand; D Poirier; C Levesque; J M Dufour; F Labrie
Journal:  Breast Cancer Res Treat       Date:  1989-10       Impact factor: 4.872

3.  Immuno-biochemical assay for determination of nuclear steroid receptors during tamoxifen therapy.

Authors:  A Vering; A Vockel; M Stegmüller; H G Bender
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

4.  Characterization of the estrogen receptor transfected MCF10A breast cell line 139B6.

Authors:  M J Pilat; J K Christman; S C Brooks
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

5.  Regulation of estrogen sulfotransferase by estrogen in MCF-7 human mammary cancer cells.

Authors:  J B Adams; R Vrahimis; N Phillips
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

6.  Evaluation of a recombinant yeast cell estrogen screening assay.

Authors:  N G Coldham; M Dave; S Sivapathasundaram; D P McDonnell; C Connor; M J Sauer
Journal:  Environ Health Perspect       Date:  1997-07       Impact factor: 9.031

7.  Regulatory function of the P295-T311 motif of the estrogen receptor alpha - does proteasomal degradation of the receptor induce emergence of peptides implicated in estrogenic responses?

Authors:  Dominique Gallo; Iman Haddad; Guy Laurent; Joëlle Vinh; Françoise Jacquemotte; Yves Jacquot; Guy Leclercq
Journal:  Nucl Recept Signal       Date:  2008-04-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.